Cargando…

Correction: Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease

Detalles Bibliográficos
Autores principales:	Ventham, Nicholas T., Gardner, Richard A., Kennedy, Nicholas A., Shubhakar, Archana, Kalla, Rahul, Nimmo, Elaine R., Fernandes, Daryl L., Satsangi, Jack, Spencer, Daniel I. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451143/ https://www.ncbi.nlm.nih.gov/pubmed/26030157 http://dx.doi.org/10.1371/journal.pone.0129335

Ejemplares similares

Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease
por: Ventham, Nicholas T., et al.
Publicado: (2015)

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)
por: Ventham, Nicholas T., et al.
Publicado: (2023)

High-Throughput Analysis and Automation for Glycomics Studies
por: Shubhakar, Archana, et al.
Publicado: (2014)

Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
por: Trbojević Akmačić, Irena, et al.
Publicado: (2015)

Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
por: Ventham, N. T., et al.
Publicado: (2016)

Two-stage Genome-wide Methylation Profiling in Childhood-onset Crohn's Disease Implicates Epigenetic Alterations at the VMP1/MIR21 and HLA Loci
por: Adams, Alex T., et al.
Publicado: (2014)

Reply
por: Nowak, Jan Krzysztof, et al.
Publicado: (2021)

Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis
por: Wang, Jingrong, et al.
Publicado: (2019)

N-glycans from serum IgG and total serum glycoproteins specific for endometriosis
por: Kovács, Zsuzsanna, et al.
Publicado: (2023)

Mass Spectrometric Screening of Ovarian Cancer with Serum Glycans
por: Kim, Jae-Han, et al.
Publicado: (2014)

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome
por: Kalla, Rahul, et al.
Publicado: (2022)

Transcription and DNA Methylation Patterns of Blood-Derived CD8(+) T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis
por: Gasparetto, Marco, et al.
Publicado: (2021)

Serum N-glycan profiles differ for various breast cancer subtypes
por: Vreeker, Gerda C. M., et al.
Publicado: (2021)

Serum components influence antibody reactivity to glycan and DNA antigens
por: Okuda, Tetsuya, et al.
Publicado: (2023)

Meta-analysis of the effect of perioperative intravenous lidocaine on return of gastrointestinal function after colorectal surgery
por: Cooke, C., et al.
Publicado: (2019)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
por: Kamm, Florian, et al.
Publicado: (2018)

Serum Protein N-Glycans in Colostrum and Mature Milk of Chinese Mothers
por: Elwakiel, Mohèb, et al.
Publicado: (2020)

N‐glycan profiling alterations of serum and immunoglobulin G in immune thrombocytopenia
por: Wang, Wei, et al.
Publicado: (2021)

Alterations in the Glycan Composition of Serum Glycoproteins in Attention-Deficit Hyperactivity Disorder
por: Kianičková, Kristína, et al.
Publicado: (2023)

Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers
por: Gebrehiwot, Abrha G., et al.
Publicado: (2018)

Gastric tubes in patients with severe brain injury
por: Lyon, R, et al.
Publicado: (2008)

Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
por: Kamm, Florian, et al.
Publicado: (2018)

Site-Specific N-Glycan Characterization of Grass Carp Serum IgM
por: Su, Yi-Ling, et al.
Publicado: (2018)

Serum N‐glycan profiling as a diagnostic biomarker for the identification and assessment of psoriasis
por: Zou, Chengyun, et al.
Publicado: (2021)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Comparison of the methods for profiling N-glycans—hepatocellular carcinoma serum glycomics study
por: Wang, Ran, et al.
Publicado: (2018)

Generalized low levels of serum N‐glycans associate with better health status
por: Fan, Jiteng, et al.
Publicado: (2023)

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
por: Ochoa-Rios, Shaaron, et al.
Publicado: (2023)

Stability of 21 Antihypertensive Drugs in Serum Collected in Standard (Nongel) Serum Tubes Versus Tubes Containing a Gel Separator
por: Hegstad, Solfrid, et al.
Publicado: (2020)

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
por: Nowak, Jan Krzysztof, et al.
Publicado: (2020)

Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease – a Longitudinal Analysis
por: Rieder, Florian, et al.
Publicado: (2011)

Analysis of Glycan Variation on Glycoproteins from Serum by the Reverse Lectin-Based ELISA Assay
por: Wu, Jing, et al.
Publicado: (2014)

Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum
por: Muthana, Saddam M., et al.
Publicado: (2016)

Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma
por: Chen, Jie, et al.
Publicado: (2015)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_et4ns9uur67lqgdmptki32v4eg